Clinical and Translational Allergy

Papers
(The H4-Index of Clinical and Translational Allergy is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Real‐life data on inactivated COVID‐19 vaccination in patients with subcutaneous allergen immunotherapy119
Epicutaneous immunotherapy for food allergy: A systematic review and meta‐analysis103
Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey42
41
Patients with suspected allergic reactions to COVID‐19 vaccines can be safely revaccinated after diagnostic work‐up40
Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps38
37
Eczema in early childhood increases the risk of allergic multimorbidity35
Dynamic trends in skin barrier function from birth to age 6 months and infantile atopic dermatitis: A Chinese prospective cohort study32
Direct and indirect costs of allergic and non‐allergic rhinitis to adults in Beijing, China31
Large‐scale plasma proteomics can reveal distinct endotypes in chronic obstructive pulmonary disease and severe asthma31
Correction to “Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety”31
Issue Information28
Sensitivity to change and minimal clinically important difference of the angioedema control test28
Relationship between longitudinal changes in type‐2 inflammation, immunoglobulin E sensitization, and clinical outcomes in young asthmatics27
27
Issue Information27
Issue Information26
Omalizumab for successful chemotherapy desensitisation: What we know so far26
Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme24
Efficacy of probiotics in pediatric atopic dermatitis: A systematic review and meta‐analysis23
Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema21
The holo beta‐lactoglobulin lozenge reduces symptoms in cat allergy—Evaluation in an allergen exposure chamber and by titrated nasal allergen challenge21
0.025009870529175